Xylo Bio

Revolutionizing brain health with precision therapies that restore and enhance neural function

Xylo is developing next-generation neurotherapeutics that enhance brain plasticity to restore and optimize cognitive and emotional function. By combining advanced neuroscience with computational drug discovery, they aim to create innovative treatments for neurological and psychiatric conditions worldwide.

Team: Joshua Ismin and Sam Banister, Co-Founders

Sam Banister and Joshua Ismin, Co-Founders